Comparison of the sensitivity and specificity of the CA19-9 and carcinoembryonic antigen assays in detecting cancer of the pancreas.
about
CA 242, a new tumour marker for pancreatic cancer: a comparison with CA 19-9, CA 50 and CEAThe clinical utility of CA 19-9 in pancreatic adenocarcinoma: diagnostic and prognostic updatesDiagnosis of pancreatic cancer using serum proteomic profiling.Unusually High Serum Levels of CA 19-9 in an Ovarian Tumour: Malignant or Benign?Circulating microRNA-214 and -126 as potential biomarkers for canine neoplastic disease.Clinical evaluation, imaging studies, indications for cytologic study and preprocedural requirements for duct brushing studies and pancreatic fine-needle aspiration: The Papanicolaou Society of Cytopathology Guidelines.ALCAM (CD166) expression and serum levels in pancreatic cancerThe value of postoperative serum carcinoembryonic antigen and carbohydrate antigen 19-9 levels for the early detection of gastric cancer recurrence after curative resection.Serum DU-PAN-2 in the differential diagnosis of pancreatic cancer: influence of jaundice and liver dysfunctionUtility of serum CA19-9 levels in the diagnosis of pancreatic ductal adenocarcinoma in an endoscopic ultrasound referral population.Plasma Shh levels reduced in pancreatic cancer patientsp53 protein expression and CA19.9 values in differential cytological diagnosis of pancreatic cancer complicated with chronic pancreatitis and chronic pancreatitisTumour markers: An overview.Macrophage migration inhibitory factor and DJ-1 in gastric cancer: differences between high-incidence and low-incidence areasThe role of carbohydrate antigen 19-9 as a tumour marker of oesophageal cancerClinical significance of CA19-9 in diagnosis of digestive tract tumorsIncreased expression of proliferating cell nuclear antigen in autoimmune hepatitis in a patient with raised serum concentration of CA19-9.Genomic and proteomic biomarkers for cancer: a multitude of opportunities.Novel blood-based microRNA biomarker panel for early diagnosis of pancreatic cancer.The Prognostic Impact of the Carcinoembryonic Antigen in Ampullary Cancer - A Retrospective Single Center Study.Comparison of a new tumour marker CA 242 with CA 19-9, CA 50 and carcinoembryonic antigen (CEA) in digestive tract diseases.The prognostic value of preoperative serum levels of CA 19-9 and CEA in patients with pancreatic cancer.Cellular fibronectin concentration in the plasma of patients with malignant and benign diseases: a comparison with CA 19-9 and CEA.Diagnostic Accuracy of a CA125-Based Biomarker Panel in Patients with Pancreatic Cancer: A Systematic Review and Meta-Analysis.
P2860
Q24678824-F3B77DA5-9FEF-4D81-9EF1-71B3B4CC7744Q26865015-CC212973-D786-4582-A16F-5528192EFA51Q31129486-940FBC3F-4CDE-42A4-8D47-733F78061FCEQ33666787-B05AC1F3-928F-44DC-A10C-C6A5A121C6D5Q33720085-8DC435C7-95FF-4812-81B2-E5796266B46FQ34127295-9D2319D2-BF09-406E-8865-52C9992A9D0AQ34321201-340515E8-E9A6-486F-B316-E9360CEA95A7Q34867093-EDBF32DC-9F5F-4655-88E9-C7FC89BE4C2AQ35983251-DD31A233-DEBA-47CC-9845-D8A2F1479A1CQ36025215-6C6DB7E5-E023-4041-AC14-1E1F96F6DC80Q36113636-13C34294-1826-4907-A813-7AC1CB80061FQ36178952-E6D20346-6236-47B5-9E99-60AD7427E4B5Q36264719-4C4B2C64-33EA-470C-8C9F-C2E47D0EA85FQ36385267-395824D3-B916-4F59-9886-EB017A6280F3Q36467207-44491032-95AE-48E5-B472-37665CF08505Q36724560-8671FD67-22B3-4718-8FD6-82357674E756Q37217854-673D0605-9DE1-4983-BD5A-1541EEFAA80EQ37363928-C7F91357-33D7-4710-B121-92C67664E5A6Q37605740-97F90006-2AE3-4BA2-AAE7-61131E835BAFQ38709332-A108D27D-E038-4F0E-A1EB-B07C4131B5E9Q41761881-41B5A884-15F7-4992-840B-2BEF6B7ED9DBQ41819905-BDFAC36E-03DC-4DE0-A07E-80ECAC766973Q41901332-E6BE3493-A743-4272-869B-7942D85BBB98Q43565999-E2AF660A-466D-44B4-8202-834AC7244131
P2860
Comparison of the sensitivity and specificity of the CA19-9 and carcinoembryonic antigen assays in detecting cancer of the pancreas.
description
1986 nî lūn-bûn
@nan
1986年の論文
@ja
1986年学术文章
@wuu
1986年学术文章
@zh
1986年学术文章
@zh-cn
1986年学术文章
@zh-hans
1986年学术文章
@zh-my
1986年学术文章
@zh-sg
1986年學術文章
@yue
1986年學術文章
@zh-hant
name
Comparison of the sensitivity ...... ecting cancer of the pancreas.
@en
Comparison of the sensitivity ...... ecting cancer of the pancreas.
@nl
type
label
Comparison of the sensitivity ...... ecting cancer of the pancreas.
@en
Comparison of the sensitivity ...... ecting cancer of the pancreas.
@nl
prefLabel
Comparison of the sensitivity ...... ecting cancer of the pancreas.
@en
Comparison of the sensitivity ...... ecting cancer of the pancreas.
@nl
P2093
P1433
P1476
Comparison of the sensitivity ...... tecting cancer of the pancreas
@en
P2093
K K Anderson
P P Toskes
S H Kurtzman
W F Sindelar
W M Steinberg
P304
P356
10.1016/0016-5085(86)90930-3
P407
P577
1986-02-01T00:00:00Z